FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

12227811000001109: Sodium dihydrogen phosphate anhydrous (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
43832301000001116 Sodium dihydrogen phosphate anhydrous (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43832401000001112 Sodium dihydrogen phosphate anhydrous en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium dihydrogen phosphate anhydrous Is a Monobasic sodium phosphate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium acid phosphate 1.72g suppository Has active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Phosphate compound 16.1mmol effervescent tablet Has active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Carbalax suppositories (Forest Laboratories UK Ltd) 12 suppository Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium acid phosphate 1.72g suppository Has specific active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Carbalax suppositories (Forest Laboratories UK Ltd) Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium acid phosphate 1.69g / Sodium bicarbonate 1.08g suppositories 12 suppository Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Phosphate Sandoz effervescent tablets (Alturix Ltd) Has specific active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Phosphate Sandoz effervescent tablets (Alturix Ltd) 100 tablet 5 x 20 tablets Has specific active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Phosphate compound 16.1mmol effervescent tablet Has specific active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium acid phosphate 1.936g effervescent tablets 100 tablet Has specific active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate anhydrous 680mg / Sodium bicarbonate 500mg suppositories Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Lecicarbon A suppositories (Aspire Pharma Ltd) Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate anhydrous 680mg / Sodium bicarbonate 500mg suppositories 10 suppository Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Lecicarbon A suppositories (Aspire Pharma Ltd) 10 suppository 2 x 5 suppositories Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate anhydrous 340mg / Sodium bicarbonate 250mg suppositories 10 suppository Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Lecicarbon C suppositories (Aspire Pharma Ltd) 10 suppository 2 x 5 suppositories Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Phosphate Sandoz effervescent tablets (Alturix Ltd) Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Phosphate Sandoz effervescent tablets (Alturix Ltd) 100 tablet 5 x 20 tablets Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium acid phosphate 1.936g effervescent tablets 100 tablet Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate anhydrous 1.936g effervescent tablets Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate dihydrate 1.69g / Sodium bicarbonate 1.08g suppositories Has specific active ingredient False Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier
Sodium dihydrogen phosphate dihydrate 1.69g / Sodium bicarbonate 1.08g suppositories Has specific active ingredient True Sodium dihydrogen phosphate anhydrous Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start